Clearbridge Health (CBH)

Clearbridge Health started at ‘buy’ with 28 cents target by Phillip on growth trajectory

SINGAPORE (Apr 1): Phillip Securities is initiating coverage of Clearbridge Health (CBH) with a “buy”.

Phillip likes CBH’s business strategy of acquiring asset-light and fast-growing healthcare segments. After the acquisition, the group will then grow the businesses through expansion in capacity, network and capabilities.

CBH is currently trying to strengthen its foothold in the Indonesian and Filipino healthcare markets.

Clearbridge Health associate Biolidics lodges prelim prospectus

SINGAPORE (Nov 26): Biolidics, a cancer diagnostic solutions developer and an associate company of Clearbridge Health, on Friday lodged a preliminary prospectus for a planned initial public offering (IPO) on the Singapore Exchange's Catalist board.

Biolidics, incorporated as Clearbridge Biomedics in 2009, specialises in developing cell enrichment systems that can be combined with other analytical tests for cancer diagnosis, prognosis and treatment selection and monitoring.

Clearbridge Health to acquire 65% stake in medical centre in Manila

SINGAPORE (Jan 4): Clearbridge Health’s wholly-owned subsidiary, Clearbridge Health (Philippines), has entered into a conditional share purchase agreement to acquire 65% of the common shares in the issued share capital of Marzan Health Care Inc for 69.6 million Philippine pesos ($1.9 million).

The target company operates a medical centre offering a wide range of services including pathology services, imaging diagnostics, dental care, as well as dialysis and renal care in Manila, Philippines.

How clear is Clearbridge Health post-listing outlook?

SINGAPORE (Dec 14): Clearbridge Health (CBH), the healthcare firm which focuses on the delivery of precision medicine, boosts a capable team to lead its expansion across Asia, says Maybank KimEng.

See: Clearbridge Health to list on Catalist; seeking to raise $24.6 million

Be informed of the stories that matter